Status:
WITHDRAWN
Safety and Efficacy Study of DuoTrav APS Versus DuoTrav
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of the study is to demonstrate that the IOP-lowering efficacy of DuoTrav APS, dosed once-daily in the morning, is non-inferior to that of DuoTrav, dosed once-daily in the morning.
Eligibility Criteria
Inclusion
- Patients with open-angle glaucoma or ocular hypertension who would benefit from a fixed combination medication, in the opinion of the investigator and who are currently on a stable treatment of IOP-lowering medication
Exclusion
- VA not worse than 0.60
- additional clinically relevant ocular or systemic conditions may be excluded
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00862472
Start Date
March 1 2009
End Date
June 1 2009
Last Update
January 18 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.